Trastuzumab Market

Trastuzumab, a monoclonal antibody against Her2, blocks the growth of cancer cells by attaching itself to Her2, preventing epidermal growth factor from attaching to Her2. Herceptin also stimulates the body's own immune cells to destroy cancer cells. Clinically, it is mainly used for metastatic breast cancer with excessive expression of her-2. Monotherapy may be used for metastatic breast cancer that has received one or more chemotherapy regimens; It can be combined with paclitaxel to treat metastatic breast cancer without chemotherapy.
Trastuzumab Market aims to provide a comprehensive presentation of the global market for Trastuzumab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Trastuzumab. Trastuzumab Market contains market size and forecasts of Trastuzumab in global, including the following market information:
Global Trastuzumab Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Trastuzumab Market Sales, 2018-2023, 2024-2032, (MT)
Global top five Trastuzumab companies in 2022 (%)
The global Trastuzumab market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Human Source Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Trastuzumab include Genentech Inc, Novartis AG, Pfizer, Abnova Corporation, InvivoGen, Celltrion, Biocon Limited and Bio-Techne, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Trastuzumab manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Trastuzumab Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (MT)
Global Trastuzumab Market Segment Percentages, by Type, 2022 (%)
Human Source
Animal Source
Global Trastuzumab Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (MT)
Global Trastuzumab Market Segment Percentages, by Application, 2022 (%)
Hospital
Medical Center
Global Trastuzumab Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (MT)
Global Trastuzumab Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Trastuzumab revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Trastuzumab revenues share in global market, 2022 (%)
Key companies Trastuzumab sales in global market, 2018-2023 (Estimated), (MT)
Key companies Trastuzumab sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Genentech Inc
Novartis AG
Pfizer
Abnova Corporation
InvivoGen
Celltrion
Biocon Limited
Bio-Techne
Outline of Major Chapters:
Chapter 1: Introduces the definition of Trastuzumab, market overview.
Chapter 2: Global Trastuzumab market size in revenue and volume.
Chapter 3: Detailed analysis of Trastuzumab manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Trastuzumab in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Trastuzumab capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.